MRI imaging signs help distinguish uterine sarcoma from fibroids

This article describes an approach to differentiating uterine leiomyosarcoma from benign leiomyomas using contrast-enhanced MRI with diffusion-weighted imaging and apparent diffusion coefficient measurement, reported to achieve 88%-94.6% accuracy. The authors note that current data suggest uterine sarcoma risk may be as high as one in 770 women undergoing surgery for presumed fibroids, and they build on the 2023 MRI Evaluation of Uterine Masses for Risk of Leiomyosarcoma consensus statement with additional practical nuances for its application.

Most relevant for: Women being evaluated for presumed uterine fibroids prior to minimally invasive surgical treatment.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.